PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2011 | 14 | 4 |

Tytuł artykułu

The transcriptomic signature of myostatin inhibitory influence on the differentiation of mouse C2C12 myoblasts

Treść / Zawartość

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
GDF8 (myostatin) is a unique cytokine strongly affecting the skeletal muscle phenotype in human and animals. The aim of the present study was to elucidate the molecular mechanism of myostatin influence on the differentiation of mouse C2C12 myoblasts, using the global-transcriptome analysis with the DNA microarray technique. Treatment with exogenous GDF8 strongly affected the growth and development of C2C12 mouse myoblasts. This was manifested by the inhibition of proliferation and differentiation as well as the impairment of cell fusion. DNA microarray analysis revealed 778 genes regulated by GDF8 in differentiating myoblasts (436 down-regulated and 235 up-regulated). Ontological analysis revealed their involvement in 17 types of biological processes, 10 types of molecular functions and 68 different signalling pathways. The effect of GDF8 was mainly mediated by the disruption of the cell cycle, calcium and insulin signalling pathways and expression of cytoskeletal and muscle specific proteins. The identified key-genes that could play a role as GDF8 targets in differentiating myoblasts are: Mef2, Hgf, Ilb1, Itgb1, Edn1, Ppargc1a.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

14

Numer

4

Opis fizyczny

p.643-652,fig.,ref.

Twórcy

autor
  • Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159, 02-776 Warsaw, Poland
autor
autor
autor

Bibliografia

  • Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529.
  • Bachinski LL, Sirito M, Bohme M, Baggerly KA, Udd B, Krahe R (2010) Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders. Muscle Nerve 42: 856-863.
  • Budasz-Świderska M, Jank M, Motyl T (2005) Transforming Growth Factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts. J Physiol Pharmacol 56: 195-214.
  • Charge SB, Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238.
  • Diel P, Baadners D, Schlupmann K, Velders M, Schwarz JP (2008) C2C12 myoblastoma cell differentiation and proliferation is stimulated by androgens and associated with a modulation of myostatin and Pax7 expression. J Mol Endocrinol 40: 231-241.
  • Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC (2009) Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4: e4937.
  • Ho CY (2010) Hypertrophic cardiomyopathy. Heart Fail Clin 6: 141-159.
  • Janot M, Audfray A, Loriol C, Germot A, Maftah A, Dupuy F (2009) Glycogenome expression dynamics during mouse C2C12 myoblast differentiation suggests a sequential reorganization of membrane glycoconjugates. BMC Genomics 10: 483.
  • Isenberg G (2004) Ca²⁺ control of transcription: can we extrapolate signaling cascades from neurons to vascular smooth muscle cells? Circ Res 94: 1276-1278.
  • Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G (2003) Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286: 263-275.
  • Konno T, Chen D, Wang L, Wakimoto H, Teekakirikul P, Nayor M, Kawana M, Eminaga S, Gorham JM, Pandya K, Smithies O, Naya FJ, Olson EN, Seidman JG, Seidman CE (2010) Heterogeneous myocyte enhancer factor- 2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 107: 18097-18102.
  • Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277: 49831-49840.
  • Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98: 9306-9311
  • McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90.
  • McPherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109: 595-601.
  • Morimoto S (2008) Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 77: 659-666.
  • Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-73.
  • Ostrander EA, Huson HJ, Ostrander GK (2009) Genetics of athletic performance. Annu Rev Genomics Hum Genet 10: 407-429.
  • Sadkowski T, Jank M, Zwierzchowski L, Oprządek J, Motyl T (2009) Comparison of skeletal muscle transcriptional profiles in dairy and beef breeds bulls. J Appl Genet 50: 109-123.
  • Sadkowski T, Jank M, Zwierzchowski L, Siadkowska E, Oprządek J, Motyl T (2008) Gene expression profiling in skeletal muscle of Holstein-Friesian bulls with single-nucleotide polymorphism in the myostatin gene 5'-flanking region. J Appl Genet 49: 237-250.
  • Sato F, Kurokawa M, Yamauchi N, Hattori MA (2006) Gene silencing of myostatin in differentiation of chicken embryonic myoblasts by small interfering RNA. Am J Physiol Cell Physiol 291: C538-545.
  • Shemyakin A, Salehzadeh F, Bohm F, Al-Khalili L, Gonon A, Wagner H, Efendic S, Krook A, Pernow J (2010) Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro. J Clin Endocrinol Metab 95: 2359-2366.
  • Shen X, Collier J, Hlaing M, Zhang L, Delshad E, Bristow J, Bernstein HS (2003) Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 226: 128-138.
  • Shi X, Garry DJ (2006) Muscle stem cells in development, regeneration, and disease. Genes Dev 20: 1692-1708.
  • Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275: 40235-40243.
  • Wagers AJ, Conboy IM (2005) Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122: 659-667
  • Wicik Z, Sadkowski T, Jank M, Motyl T (2010) Transcriptional pattern of TGF-β1 inhibitory effect on mouse C2C12 myoblasts differentiation. Pol J Vet Sci 13: 629-638.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-b6553518-9c88-4618-ab90-4ed900949337
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.